| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ff186a9f9018962a9e9ccb726e7a16a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
| filingDate |
2008-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_456bd3b3a60c853120b5470baa746d99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ca39879b56356ebad405edcd6c09b53 |
| publicationDate |
2018-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2657937-T3 |
| titleOfInvention |
Methods and injectable meclizine formulations |
| abstract |
An injectable pharmaceutical formulation suitable for treating a condition of vertigo of a subject, or suitable for treating or preventing a condition of nausea or vomiting of a subject, the injectable pharmaceutical formulation essentially consisting of: a therapeutically effective amount of meclizine; a molar excess of chemically modified cyclodextrin selected from the group consisting of 2-hydroxypropyl beta-cyclodextrin and sulfobutyl ether-beta-cyclodextrin; an aqueous vehicle medium, the aqueous vehicle medium having a pH between 3 and 7, the pharmaceutically acceptable formulation being suitable for injection; and optionally a pharmaceutically acceptable preservative, a pharmaceutically acceptable antioxidant, a pharmaceutically acceptable osmolality adjusting agent, or a combination thereof. |
| priorityDate |
2007-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |